5ÔÂ24ÈÕ£¬£¬£¬£¬£¬£¬2121·Ç·²×ÔÖ÷Ñз¢µÄÖÐÊàÉñ¾ÏµÍ³£¨CNS£©Ö×ÁöϵÁзÖ×Ó¼ì²âÏîÄ¿ÕýʽÉÏÏß¡£¡£¡£¡£¡£¸ÃϵÁвúÆ·»ùÓÚNGS¡¢PCR¡¢¼×»ù»¯Ð¾Æ¬µÈ¶àÊÖÒÕÆ½Ì¨£¬£¬£¬£¬£¬£¬ÎªCNSÖ×ÁöµÄ¸¨ÖúÕï¶Ï¡¢Ô¤ºóÆÀ¹À¡¢¾«×¼ÓÃÒ©µÈÌṩ¸ü¸ß¼ÛÖµµÄ²Î¿¼ÐÅÏ¢£¬£¬£¬£¬£¬£¬Ò»Á¬Öª×ãÁÙ´²Ò½Éú¾«×¼ÕïÁÆÐèÇ󡣡£¡£¡£¡£
ÖÐÊàÉñ¾ÏµÍ³£¨CNS£©Ö×Áö£¬£¬£¬£¬£¬£¬Éæ¼°Ò»×éÔ´×ÔÄÔÓë¼¹Ëè×éÖ¯µÄÁ¼ÐԺͶñÐÔ¼²²¡£¡£¡£¡£¡£¬£¬£¬£¬£¬£¬¹Å°åÉÏÒÀ¾Ý×éÖ¯²¡ÀíÑ§ÌØÕ÷·ÖÀà¡£¡£¡£¡£¡£È»¶ø£¬£¬£¬£¬£¬£¬Ëæ×ŽüÄêÀ´·Ö×ÓÉúÎïѧµÄÏ£Íû£¬£¬£¬£¬£¬£¬ÌØÊâÊÇзÖ×Ó±ê¼ÇÎïµÄÓ¿ÏÖ£¬£¬£¬£¬£¬£¬CNSÖ×ÁöµÄ·ÖÀàϵͳÒÑÂõÈë·Ö×ÓÕï¶Ï¸¨ÖúµÄʱ´ú£¬£¬£¬£¬£¬£¬Õâ²»µ«¼ÓÉîÁËÎÒÃǶÔÖ×ÁöʵÖʵÄÃ÷È·£¬£¬£¬£¬£¬£¬»¹Ôö½øÁËÔ½·¢¸öÐÔ»¯¡¢¸ßЧµÄÖÎÁÆÕ½ÂÔ£¬£¬£¬£¬£¬£¬ÏÔÖøÔöÇ¿ÁË»¼ÕßµÄÖÎÁÆÐ§¹ûºÍÉúÑÄÖÊÁ¿¡£¡£¡£¡£¡£
2016Ä꣬£¬£¬£¬£¬£¬ÌìÏÂÎÀÉú×éÖ¯£¨WHO£©ÒýÈë·Ö×Ó·ÖÐͱê×¼£¬£¬£¬£¬£¬£¬ÎªCNSÖ×ÁöµÄ·ÖÀàϵͳ¼ÓÈëÁË·Ö×Ó²ãÃæµÄ¿¼Á¿¡£¡£¡£¡£¡£2021Ä꣬£¬£¬£¬£¬£¬WHOÐû²¼µÄCNSÖ×Áö·ÖÀàµÚÎå°æÖУ¬£¬£¬£¬£¬£¬½øÒ»²½½«·Ö×ÓÕï¶Ï¡¢×éÖ¯ÐÎ̬ѧ¼°ÃâÒß×黯ÆÊÎöÏàÍŽᣬ£¬£¬£¬£¬£¬×é³ÉÁËCNSÖ×Áö¾«×¼Ò½ÁƵÄлùʯ¡£¡£¡£¡£¡£ ΪÁ˽øÒ»²½Öª×ãÁÙ´²¾«×¼ÕïÁÆÐèÇ󣬣¬£¬£¬£¬£¬ÌáÉýCNSÖ×ÁöÕï¶Ïˮƽ£¬£¬£¬£¬£¬£¬2121·Ç·²ÐÂÍÆ³öÁËһϵÁÐCNSÖ×Áö¼ì²âÏîÄ¿¡£¡£¡£¡£¡£
ÖÐÊàÉñ¾ÏµÍ³Ö×Áö»ùÒò¼ì²â-NGSƽ̨
»ùÓÚ¶àÖØPCRµÄNGSÊÖÒÕ£¬£¬£¬£¬£¬£¬¸Ã²úÆ·¿ÉÒ»´ÎÐÔ¼ì²âÓëÄÔÖ×ÁöÏà¹ØµÄ¶àÖÖ±äÒìÐÅÏ¢£¨°üÀ¨SNV/InDel/CNV/LOH/Fusion£©£¬£¬£¬£¬£¬£¬º¸Ç¸ßÖ¤¾ÝÆ·¼¶µÄÒ©Îï°Ðµã£¬£¬£¬£¬£¬£¬ÎªÄÔÖ×Áö¸¨ÖúÕï¶Ï¡¢Ô¤ºóÆÀ¹À¡¢¾«×¼ÓÃÒ©Ìṩ²Î¿¼ÐÅÏ¢£¬£¬£¬£¬£¬£¬¸¨ÖúÁÙ´²Öƶ©¸öÌ廯ÕïÁƼƻ®¡£¡£¡£¡£¡£

ÖÐÊàÉñ¾ÏµÍ³Ö×Áö»ùÒò¼ì²â-PCRƽ̨ ÄÔ½ºÖÊÁöMGMT¼×»ù»¯¼ì²â£º×¨ÃÅÕë¶ÔÄÔ½ºÖÊÁö»¼ÕßµÄMGMTÆô¶¯×ÓÇøÓòµÄ¼×»ù»¯×´Ì¬¾ÙÐмì²â¡£¡£¡£¡£¡£¸Ã²úÆ·»ùÓÚÓ«¹âPCRÒªÁ죬£¬£¬£¬£¬£¬¼´Í¨¹ýÌØÒìÐÔÓ«¹â̽Õë¼ì²âMGMT¼×»ù»¯ÈÈÃÅÇøÓòµÄ7¸öCpGλµãÀ´ÆÊÎöMGMTÆô¶¯×Ó¼×»ù»¯ÇéÐΣ¬£¬£¬£¬£¬£¬Õ¹ÍûÄÔ½ºÖÊÁö»¼Õß¶ÔÌæÄªßò°·µÈÒ©ÎïÁÆÐ§ºÍÔ¤ºó¡£¡£¡£¡£¡£ ÖÐÊàÉñ¾ÏµÍ³Ö×Áö»ùÒò¼ì²â-¼×»ù»¯Ð¾Æ¬
ÄÔÖ×Áö¼×»ù»¯·ÖÐͼì²â£º×¨ÃÅÕë¶ÔÄÔÖ×Áö·ÖÀàµÄÅбðÕï¶ÏºÍ·Ö×ÓÑÇÐÍÆÊÎö£¬£¬£¬£¬£¬£¬ÓÈÆäÊÇÒÉÄÑÕï¶ÏµÄÄÔÖ×Áö»¼Õß¡£¡£¡£¡£¡£¸Ã²úÆ·ÊÇ»ùÓÚ935kоƬ¶ÔÈËÈ«»ùÒò×éÔ¼935,000¸öCpGλµãµÄ¼×»ù»¯×´Ì¬¾ÙÐмì²â£¬£¬£¬£¬£¬£¬ÊµÏÖÄÔÖ×Áö¾«×¼µÄ·Ö×ÓÑÇÐÍ£¬£¬£¬£¬£¬£¬¸¨Öú²¡ÀíÕï¶Ï¡£¡£¡£¡£¡£
³ýÉÏÊöÐÂÉÏÏßÏîĿ֮Í⣬£¬£¬£¬£¬£¬2121·Ç·²ÒÑÉÏÏßµÄÄÔ½ºÖÊÁö¼ì²âÏîÄ¿£¬£¬£¬£¬£¬£¬»¹°üÀ¨È¾É«Ìå1p/19qÔÓºÏÐÔȱʧ¡¢IDH1/2Í»±ä¼ì²â¡¢TERT»ùÒòÆô¶¯×ÓÍ»±ä¼ì²â¡¢BRAF V600EÍ»±ä¼ì²âµÈ£¬£¬£¬£¬£¬£¬½¨ÉèÁËÒ»Ì×ÍêÕûµÄÄÔÖ×Áö·Ö×ÓÕï¶Ï½â¾ö¼Æ»®¡£¡£¡£¡£¡£
2121·Ç·²Æð¾¢¿ªÕ¹ÓëÄÔÖ×ÁöÏà¹Ø¿ÆÑÐÏîÄ¿£¬£¬£¬£¬£¬£¬´ËǰÒѼÓÈëÓɸ´µ©´óѧÁ¥ÊôÎ÷ÔÀÒ½ÔºÖ÷µ¼µÄ¿Æ¼¼²¿2023Äê¶È¡°½Ò°ñ¹Ò˧¡±ÖصãÏîÄ¿¡ª¡ª¡°ÄÔ½ºÖÊÁö×ÛºÏÕïÁÆÐÂÊÖÒÕ¿ª·¢Óëת»¯Ó¦ÓÃÑо¿¡±ÏîÄ¿£¬£¬£¬£¬£¬£¬×¨×¢ÓÚÒºÌå»î¼ì±ê¼ÇÎïÒªº¦Ñз¢»·½Ú£¬£¬£¬£¬£¬£¬¼ÓËÙ¿ÆÑÐÖÁÁÙ´²×ª»¯¡£¡£¡£¡£¡£
2121·Ç·²Êǹú¼ÒÊ×ÅúÖ×ÁöÕï¶ÏÓëÖÎÁÆÏîÄ¿¸ßͨÁ¿»ùÒò²âÐòÊÖÒÕÁÙ´²Ó¦ÓÃÊԵ㵥λ¡¢Ê×Åú»ùÒò¼ì²âÊÖÒÕÓ¦ÓÃÊ÷Ä£ÖÐÐÄ¡£¡£¡£¡£¡£×ܲ¿ÊµÑéÊÒÒÑ»ñµÃCAP¹ú¼ÊȨÍþÈÏÖ¤£¬£¬£¬£¬£¬£¬ÑÏ¿áÆ¾Ö¤ISO 15189ÈϿɺÍÃÀ¹úCAPÈÏÖ¤ÒªÇó¾ÙÐÐʵÑéÊÒ±ê×¼ºÍ¹æ·¶µÄ¹ÜÀí£¬£¬£¬£¬£¬£¬Æð¾¢¼ÓÈë²¢¸ßˮƽͨ¹ýº£ÄÚÍâ¶àÏî¸ßͨÁ¿²âÐòÄÜÁ¦ÆÀ¹À¡£¡£¡£¡£¡£ Ëæ×Åмì²âÏîÄ¿µÄÉÏÏߣ¬£¬£¬£¬£¬£¬2121·Ç·²½«¼ÌÐøÑÏ¿á°Ñ¿Ø¸÷¸ö¼ì²â»·½Ú£¬£¬£¬£¬£¬£¬ÖúÁ¦ÓÚ¸ßЧºÍ¸öÐÔ»¯ÕïÖμƻ®µÄÑ¡Ôñ£¬£¬£¬£¬£¬£¬Îª¾«×¼Ò½ÁƵÄÁÙ´²Ó¦ÓÃТ˳Á¦Á¿£¬£¬£¬£¬£¬£¬ÎªÊµÏÖ¡°ÈùúÈËÒ»ÂɵطÖÏí¿µ½¡¡±µÄʹÃü¶ø²»Ð¸Æð¾¢¡£¡£¡£¡£¡£ ²Î¿¼ÎÄÏ× [1] Weller M, Wick W, Aldape K, Brada M, Berger M, Pfister SM, Nishikawa R, Rosenthal M, Wen PY, Stupp R, Reifenberger G. Glioma. Nat Rev Dis Primers. 2015 Jul 16;1:15017. doi: 10.1038/nrdp.2015.17. PMID: 27188790. [2] Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106. PMID: 34185076; PMCID: PMC8328013. [3] ÄÔ½ºÖÊÁöÕïÁÆÖ¸ÄÏ£¨2022Äê°æ£©